Molecular epidemiology of nontypeable Haemophilus influenzae causing community-acquired pneumonia in adults

PLoS One. 2013 Dec 13;8(12):e82515. doi: 10.1371/journal.pone.0082515. eCollection 2013.

Abstract

Nontypeable Haemophilus influenzae (NTHi) is an opportunistic pathogen which causes a variety of respiratory infections. The objectives of the study were to determine its antimicrobial susceptibility, to characterize the β-lactam resistance, and to establish a genetic characterization of NTHi isolates. Ninety-five NTHi isolates were analyzed by pulsed field gel electrophoresis (PFGE) and multi locus sequence typing (MLST). Antimicrobial susceptibility was determined by microdilution, and the ftsI gene (encoding penicillin-binding protein 3, PBP3) was PCR amplified and sequenced. Thirty (31.6%) isolates were non-susceptible to ampicillin (MIC ≥ 2 mg/L), with 10 of them producing β-lactamase type TEM-1 as a resistance mechanism. After ftsI sequencing, 39 (41.1%) isolates showed amino acid substitutions in PBP3, with Asn526 → Lys being the most common (69.2%). Eighty-four patients were successfully treated with amoxicillin/clavulanic acid, ceftriaxone and levofloxacin. Eight patients died due either to aspiration or complication of their comorbidities. In conclusion, NTHi causing CAP in adults shows high genetic diversity and is associated with a high rate of reduced susceptibility to ampicillin due to alterations in PBP3. The analysis of treatment and outcomes demonstrated that NTHi strains with mutations in the ftsI gene could be successfully treated with ceftriaxone or fluoroquinolones.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / epidemiology*
  • Female
  • Genotype
  • Haemophilus Infections / drug therapy
  • Haemophilus Infections / epidemiology*
  • Haemophilus influenzae / drug effects
  • Haemophilus influenzae / genetics*
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Molecular Epidemiology
  • Mutation
  • Penicillin-Binding Proteins / genetics
  • Phenotype
  • Phylogeny
  • Pneumonia, Bacterial / drug therapy
  • Pneumonia, Bacterial / epidemiology*
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents
  • Penicillin-Binding Proteins

Grants and funding

This study was supported by a grant from the Fondo de Investigaciones Sanitarias de la Seguridad Social (PI0901904), by CIBER de Enfermedades Respiratorias (CIBERES - CB06/06/0037), run by the ISCIII (Instituto de Salud Carlos III), Madrid, Spain, and by Spanish Network for Research on Infectious Diseases (REIPI, RD12/0015), run by ISCIII, Madrid, Spain. CP was supported by grants from AGAUR-FI (Generalitat de Catalunya, Spain) and from FPU (Formación de Profesorado Universitario, Ministerio de Educación, Spain). SM was supported by a “Sara Borrell Postdoctoral Contract, CD10/00298” from the Instituto de Salud Carlos III (ISCIII), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.